Conference Proceedings July 8, 2022Evaluation of Global Progress Towards HBV and HCV EliminationJuly 8, 2022The Impact of Vaccination on the Global and Regional Paediatric Prevalence of Hepatitis B from 1985–2022July 6, 2022The Elimination of Hepatitis C in the Cherokee Nation: The Impact of Harm ReductionJune 27, 2022Economic Investment and Strategies to Eliminate Chronic Hepatitis C in MexicoJune 26, 2022Hepatitis C Prevalence and Elimination Planning in Pakistan, a Bottom-Up ApproachJune 25, 2022Catalytic Funding and Netflix Model to Finance Viral Hepatitis EliminationJune 24, 2022The Disease Burden of Hepatitis B and C from 2015–2030: The Long and Winding Road Towards EliminationJune 23, 2022The Incidence of Chronic HBV by Age, 2022June 22, 2022Updated Evaluation of Global Progress Towards HBV and HCV Elimination, Preliminary Data Through 2021June 21, 2022Population Adjusted Prevalence of Hepatitis Delta Virus in 16 Countries and TerritoriesNovember 22, 2021Modeling disease burden of nonalcoholic fatty liver disease (NAFLD) in JapanNovember 22, 2021Simplified test and treat protocols for population level screening and elimination of hepatitis B and hepatitis C in UzbekistanNovember 22, 2021Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progressNovember 22, 2021Cost-Effectiveness Analysis of Treating All HBsAg+ Individuals in the United StatesNovember 22, 2021Global HBV Cascade of Care: The Pre-COVID-19 BaselineNovember 18, 2021The global non-alcoholic fatty liver disease (NAFLD) preparedness index: Are countries ready to tackle the challenge?November 18, 2021Simplified test & treat protocols to eliminate HCV & HBV in UzbekistanNovember 18, 2021The impact of expanding antiviral treatment criteria at a population level in the Republic of Korea: A modeling analysisNovember 22, 2020The Hep-CORE Policy Score: A European hepatitis C national policy implementation rankingNovember 22, 2020Do countries have the right policies to eliminate viral hepatitis B and C: a secondary analysis of the Lancet GastroHep Viral Hepatitis CommissionNovember 22, 2020Anticipated timing of elimination of hepatitis C virus in Canada’s four most populous provincesNovember 22, 2020Global timing of hepatitis C virus elimination in high-income countries: an updated analysisNovember 22, 2020Catalytic funding for viral hepatitis elimination program in UzbekistanNovember 22, 2020Global prevalence of hepatitis C virus in women of childbearing age in 2019: A modeling studyNovember 22, 2020NAFLD Disease Burden – Canada, 2019-2030November 22, 2019Modeling NAFLD-Related Disease Progression among the PITER SVR12 CohortNovember 22, 2019Screening strategies for hepatitis C virus elimination in ItalyNovember 22, 2019The Consensus Hepatitis C Cascade of Care: Methodology and initial findings from three countriesNovember 22, 2019Achieving accelerated elimination of hepatitis C virus infection by 2025: a case study in FranceNovember 22, 2019Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targetsNovember 22, 2019Eliminating Hepatitis C in Portugal: Treatment and Diagnosis Requirements for Two TimelinesNovember 22, 2018The Disease Burden of Hepatitis B in Republic of Uzbekistan: Strategies Providing Hope for the FutureNovember 22, 2018Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Targets for Hepatitis C in the South East Asia RegionNovember 22, 2018Hepatitis C Infection in the Eastern Mediterranean Region: The Current Burden of Disease and a Road Map for Achieving the WHO Global Health Sector Strategy TargetsNovember 22, 2018Eliminating Hepatitis C Virus (HCV) in IndonesiaNovember 22, 2018Disease Burden of Hepatitis B in the Kyrgyz Republic: A Focus on PreventionNovember 22, 2018Achieving the World Health Organization Global Health Sector Strategies for Hepatitis C in the WHO Western Pacific Region: A Modelling StudyNovember 22, 2018The Global Prevalence of HBsAg by Age in 2016 and the Case for Universal Treatment in Low and Middle Income CountriesNovember 22, 2018The current and future disease burden of hepatitis B virus in the general population and among five-year-olds in the Eastern Mediterranean RegionNovember 22, 2018Quantifying the impact of achieving the World Health Organization global health sector strategy goals for hepatitis C in the EURO regionNovember 22, 2018Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Goals for Hepatitis C in the AFRO RegionNovember 22, 2018Micro-Elimination of Chronic Hepatitis C in Switzerland: Modelling the Swiss Hepatitis Strategy Goals in Urban and Rural RegionsNovember 22, 2018Impact of the Hepatitis B Vaccine Birth-Dose on Perinatal Incidence between 2017-2050: Results from 17 WHO AFRO CountriesNovember 22, 2018Hepatitis C infection in the Pan American Health Organization Region: The current burden of disease and a road map for achieving the World Health Organization Global Health Sector Strategy GoalsNovember 22, 2018Forecasting liver disease burden based on a real life cohort of linked-to-care patients in Italy. Does the “hidden portion of the iceberg” matter to reach the WHO HCV elimination goals in high HCV prevalent countries?November 22, 2018Achieving World Health Organization Targets for Hepatitis B in Infants and 5-year-olds by 2030: Results from 17 WHO AFRO CountriesNovember 22, 2018Achieving World Health Organization Targets for Hepatitis B by 2030: Results from 17 WHO AFRO CountriesNovember 22, 2018Estimates and projection of disease burden and economic analysis for hepatitis C in Viet NamNovember 22, 2018Estimates and projection of disease burden and economic analysis for hepatitis B in Viet NamNovember 22, 2018Global Cascade of Care for HBV and HCVNovember 22, 2018Should changing epidemiology change HAV vaccination policy?November 22, 2018Elimination of Hepatitis C in Brazil is Cost-Saving – courtesy of Ministry of Health, Brasilia, BrazilNovember 22, 2018The value proposition of NASH therapy on the burden of disease related to obesity
July 8, 2022The Impact of Vaccination on the Global and Regional Paediatric Prevalence of Hepatitis B from 1985–2022
June 24, 2022The Disease Burden of Hepatitis B and C from 2015–2030: The Long and Winding Road Towards Elimination
June 22, 2022Updated Evaluation of Global Progress Towards HBV and HCV Elimination, Preliminary Data Through 2021
November 22, 2021Simplified test and treat protocols for population level screening and elimination of hepatitis B and hepatitis C in Uzbekistan
November 22, 2021Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
November 18, 2021The global non-alcoholic fatty liver disease (NAFLD) preparedness index: Are countries ready to tackle the challenge?
November 18, 2021The impact of expanding antiviral treatment criteria at a population level in the Republic of Korea: A modeling analysis
November 22, 2020The Hep-CORE Policy Score: A European hepatitis C national policy implementation ranking
November 22, 2020Do countries have the right policies to eliminate viral hepatitis B and C: a secondary analysis of the Lancet GastroHep Viral Hepatitis Commission
November 22, 2020Anticipated timing of elimination of hepatitis C virus in Canada’s four most populous provinces
November 22, 2020Global timing of hepatitis C virus elimination in high-income countries: an updated analysis
November 22, 2020Global prevalence of hepatitis C virus in women of childbearing age in 2019: A modeling study
November 22, 2019The Consensus Hepatitis C Cascade of Care: Methodology and initial findings from three countries
November 22, 2019Achieving accelerated elimination of hepatitis C virus infection by 2025: a case study in France
November 22, 2019Global timing of hepatitis C virus elimination: estimating the year countries will achieve the World Health Organization elimination targets
November 22, 2019Eliminating Hepatitis C in Portugal: Treatment and Diagnosis Requirements for Two Timelines
November 22, 2018The Disease Burden of Hepatitis B in Republic of Uzbekistan: Strategies Providing Hope for the Future
November 22, 2018Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Targets for Hepatitis C in the South East Asia Region
November 22, 2018Hepatitis C Infection in the Eastern Mediterranean Region: The Current Burden of Disease and a Road Map for Achieving the WHO Global Health Sector Strategy Targets
November 22, 2018Achieving the World Health Organization Global Health Sector Strategies for Hepatitis C in the WHO Western Pacific Region: A Modelling Study
November 22, 2018The Global Prevalence of HBsAg by Age in 2016 and the Case for Universal Treatment in Low and Middle Income Countries
November 22, 2018The current and future disease burden of hepatitis B virus in the general population and among five-year-olds in the Eastern Mediterranean Region
November 22, 2018Quantifying the impact of achieving the World Health Organization global health sector strategy goals for hepatitis C in the EURO region
November 22, 2018Quantifying the Impact of Achieving the World Health Organization Global Health Sector Strategy Goals for Hepatitis C in the AFRO Region
November 22, 2018Micro-Elimination of Chronic Hepatitis C in Switzerland: Modelling the Swiss Hepatitis Strategy Goals in Urban and Rural Regions
November 22, 2018Impact of the Hepatitis B Vaccine Birth-Dose on Perinatal Incidence between 2017-2050: Results from 17 WHO AFRO Countries
November 22, 2018Hepatitis C infection in the Pan American Health Organization Region: The current burden of disease and a road map for achieving the World Health Organization Global Health Sector Strategy Goals
November 22, 2018Forecasting liver disease burden based on a real life cohort of linked-to-care patients in Italy. Does the “hidden portion of the iceberg” matter to reach the WHO HCV elimination goals in high HCV prevalent countries?
November 22, 2018Achieving World Health Organization Targets for Hepatitis B in Infants and 5-year-olds by 2030: Results from 17 WHO AFRO Countries
November 22, 2018Achieving World Health Organization Targets for Hepatitis B by 2030: Results from 17 WHO AFRO Countries
November 22, 2018Estimates and projection of disease burden and economic analysis for hepatitis C in Viet Nam
November 22, 2018Estimates and projection of disease burden and economic analysis for hepatitis B in Viet Nam
November 22, 2018Elimination of Hepatitis C in Brazil is Cost-Saving – courtesy of Ministry of Health, Brasilia, Brazil
English 
Spanish 
French 
Chinese 
Russian 
Arabic